URINARY PROCOAGULANT AND FIBRINOLYTIC-ACTIVITY IN HUMAN GLOMERULONEPHRITIS - RELATIONSHIP WITH RENAL-FUNCTION

被引:13
作者
COLUCCI, M
SEMERARO, N
MONTEMURRO, P
CHIUMARULO, P
TRIGGIANI, R
MORRONE, LF
SCHENA, FP
机构
[1] UNIV BARI, IST PATOL GEN, I-70124 BARI, ITALY
[2] UNIV BARI, CATTEDRA NEFROL, I-70124 BARI, ITALY
关键词
D O I
10.1038/ki.1991.153
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Fibrin deposition in kidney is a common event in some forms of human and experimental glomerulonephritis, and is thought to result from local activation of blood coagulation and/or impaired removal by the fibrinolytic system. We studied the urinary procoagulant and fibrinolytic activities in 46 patients with renal disease (26 with IgA nephritis, 13 with other forms of glomerulonephritis and 7 with non-inflammatory kidney disease) and in 15 matched healthy subjects, as possible indicators of the coagulation-fibrinolysis balance in kidney. Procoagulant activity was slightly but not significantly increased in patients with serum creatinine levels higher than 1.5 mg/dl (group II) as compared with patients with normal creatinine (group I) and controls. It was identified as tissue factor by biological criteria (dependence on factor VII). Fibrinolysis studies showed that both plasminogen activator activity and urokinase antigen were significantly lower in group II than in group I patients and controls (P < 0.0005). Reduced fibrinolytic activity in patients' urine was due to decreased excretion of urokinase since no inhibitor was detected by both fibrin autography and functional assay. No differences were found between patients and controls in plasma fibrinolytic activity, plasminogen activator inhibitor, and procoagulant activity of blood monocytes. The urinary changes in severe renal disease may reflect an unbalance of the coagulation-fibrinolysis equilibrium in kidney and might be of pathogenetic and clinical relevance.
引用
收藏
页码:1213 / 1217
页数:5
相关论文
共 32 条
[1]   THE FIBRIN PLATE METHOD FOR ESTIMATING FIBRINOLYTIC ACTIVITY [J].
ASTRUP, T ;
MULLERTZ, S .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1952, 40 (02) :346-351
[2]  
BERGSTEIN JM, 1973, THROMB DIATH HAEMOST, V29, P27
[3]   ISOLATION OF LYMPHOCYTES, GRANULOCYTES AND MACROPHAGES [J].
BOYUM, A .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1976, :9-15
[4]  
BRENTJENS JR, 1987, LAB INVEST, V57, P107
[5]   PROCOAGULANT ACTIVITY IN KIDNEYS OF NORMAL AND BACTERIAL LIPOPOLYSACCHARIDE TREATED RABBITS [J].
BRUKMAN, J ;
WIGGINS, RC .
KIDNEY INTERNATIONAL, 1987, 32 (01) :31-38
[6]   URINARY TISSUE FACTOR ACTIVITY IN MALIGNANCY [J].
CARTY, N ;
TAYLOR, I ;
ROATH, OS ;
ELBARUNI, K ;
FRANCIS, JL .
THROMBOSIS RESEARCH, 1990, 57 (03) :473-478
[7]  
CIEPLAK W, 1985, THROMB HAEMOSTASIS, V53, P36
[8]   MONOCYTE PROCOAGULANT ACTIVITY IN GLOMERULONEPHRITIS ASSOCIATED WITH SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
COLE, EH ;
SCHULMAN, J ;
UROWITZ, M ;
KEYSTONE, E ;
WILLIAMS, C ;
LEVY, GA .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 75 (03) :861-868
[9]   GENERATION IN PLASMA OF A FAST-ACTING INHIBITOR OF PLASMINOGEN-ACTIVATOR IN RESPONSE TO ENDOTOXIN STIMULATION [J].
COLUCCI, M ;
PARAMO, JA ;
COLLEN, D .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 75 (03) :818-824
[10]  
GIROUX L, 1979, LAB INVEST, V40, P415